The Chocolate Touch Study (NCT02924857)

🧪 Interventions in This Study

• Chocolate Touch (DEVICE)
• Lutonix Drug Coated Balloon (DEVICE)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (20 Sites)

• Cardiac and Vascular Institute — Gainesville, Florida
• Mt. Sinai - Miami — Miami Beach, Florida
• Emory University — Atlanta, Georgia
• Cardiovascular Institute of the South — Houma, Louisiana
• Michigan Outpaitient Vascular Institution — Dearborn, Michigan
• Jackson Heart — Jackson, Mississippi
• St. Luke's Hospital — Kansas City, Missouri
• Mt. Sinai Heart — New York, New York
• Columbia University Medical Center / NewYork Presbyterian Hospital — New York, New York
• Univeristy Hospitals Cleveland Medical Center — Cleveland, Ohio
• Penn State Health Holy Spirit Medical Center — Camp Hill, Pennsylvania
• Pinnacle Health Cardiovascular Institute — Wormleysburg, Pennsylvania
• Lankenau Medical Center — Wynnewood, Pennsylvania
• MIssion Research — New Braunfels, Texas
• Swedish Medical Center — Seattle, Washington
• Medical University of Graz - LKH Univ.-Klinikum Graz — Graz,
• Angiologie - Hansuchkrankenhaus — Vienna,
• Universitat Herz-Zentrum — Bad Krozingen,
• Auckland City Hospital — Auckland,
• Waikato Hospital — Hamilton,

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Peripheral Artery Disease (PAD)

• Hemodynamic Parameters in People With Atherosclerotic Vascular Disease Referred to a Secondary Prevention and Cardiovascular Rehabilitation Program — Lévis, Quebec
• Detecting Peripheral Artery Disease With the Pulse — Omaha, Nebraska
• Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease — Alexander City, Alabama
• Using Near-Infrared Light to Better Understand Peripheral Artery Disease — Arlington, Texas
• Serranator POINT FORCE Registry — Scottsdale, Arizona

Explore by condition: All Peripheral Artery Disease (PAD) clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Review the official NIH record below to find the coordinating site.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.